These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6158053

  • 1. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T, Beyth Y, Abramsky O.
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3635-9. PubMed ID: 6158053
    [Abstract] [Full Text] [Related]

  • 2. Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor.
    Abramsky O, Brenner T, Lisak RP, Zeidman A, Beyth Y.
    Lancet; 1980 Jun; 2(8156-8157):1333-5. PubMed ID: 92675
    [Abstract] [Full Text] [Related]

  • 3. Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor.
    Brenner T, Abramsky O, Lisak RP.
    Ann N Y Acad Sci; 1981 Jun; 377():208-21. PubMed ID: 6176166
    [Abstract] [Full Text] [Related]

  • 4. Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
    Abramsky O, Brenner T.
    Isr J Med Sci; 1979 Nov; 15(11):943-5. PubMed ID: 93589
    [No Abstract] [Full Text] [Related]

  • 5. Neonatal myasthenia gravis. Anti-acetylcholine receptor antibodies in the amniotic fluid.
    Morel E, Bach JF, Briard ML, Aubry JP.
    J Neuroimmunol; 1984 Aug; 6(5):313-7. PubMed ID: 6746895
    [Abstract] [Full Text] [Related]

  • 6. Prevention of experimental autoimmune myasthenia gravis in rats by fetal alpha-fetoprotein-rich fractions.
    Brenner T, Zielinski A, Argov Z, Abramsky O.
    Tumour Biol; 1984 Aug; 5(5):263-74. PubMed ID: 6085187
    [Abstract] [Full Text] [Related]

  • 7. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B, Harrison R, Lunt GG, Morris H, Savage-Marengo T, Stephenson FA.
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [Abstract] [Full Text] [Related]

  • 8. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H, Hayashi K, Ohta K, Itoh N, Nishitani H, Ohta M.
    Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390
    [Abstract] [Full Text] [Related]

  • 9. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B, Morel E, Bach JF.
    C R Acad Sci III; 1984 Oct; 298(16):449-56. PubMed ID: 6428718
    [Abstract] [Full Text] [Related]

  • 10. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL, Ringel SP, Cook JD, Engel WK, Eldefrawi ME, McFarlin DE.
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [Abstract] [Full Text] [Related]

  • 11. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
    Almon RR, Andrew CG, Appel SH.
    Science; 1974 Oct 04; 186(4158):55-7. PubMed ID: 4421998
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T, Raftery MA.
    J Supramol Struct; 1980 Oct 04; 14(3):267-79. PubMed ID: 6971372
    [Abstract] [Full Text] [Related]

  • 13. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J, Wray DW, Pizzighella S, Hall Z, Vincent A.
    Muscle Nerve; 1990 May 04; 13(5):407-13. PubMed ID: 2345558
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B, Morel E, Bach JF.
    J Neuroimmunol; 1986 Jul 04; 12(1):65-74. PubMed ID: 3711314
    [Abstract] [Full Text] [Related]

  • 15. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
    Merlie JP, Heinemann S, Einarson B, Lindstrom JM.
    J Biol Chem; 1979 Jul 25; 254(14):6328-32. PubMed ID: 447717
    [Abstract] [Full Text] [Related]

  • 16. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S, Tsuji R, Oda K.
    Ann Neurol; 1984 Feb 25; 15(2):195-200. PubMed ID: 6367620
    [Abstract] [Full Text] [Related]

  • 17. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB, Appel SH.
    Ann Neurol; 1978 Sep 25; 4(3):250-2. PubMed ID: 718136
    [Abstract] [Full Text] [Related]

  • 18. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
    Besinger UA, Toyka KV, Hömberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A.
    Neurology; 1983 Oct 25; 33(10):1316-21. PubMed ID: 6684226
    [Abstract] [Full Text] [Related]

  • 19. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I, Newsom-Davis J.
    Ann Neurol; 1991 Oct 25; 30(4):550-7. PubMed ID: 1665051
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation.
    Brenner T, Abramsky O.
    Immunol Lett; 1981 Aug 25; 3(3):163-7. PubMed ID: 6169635
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.